Form 4: IBM CEO Arvind Krishna Receives Significant Equity Grant

Sentiment:

Insider Transaction Disclosure


IBM's Chairman, President & CEO, Arvind Krishna, received grants of 22,518 Restricted Stock Units and 90,071 Employee Stock Options.

Summary

  • Arvind Krishna, IBM's Chairman, President & CEO, was granted 22,518 Restricted Stock Units (RSUs) on February 26, 2026.
  • These RSUs have a price of $0.00, indicating they are grants, and are payable in cash or the company's common stock upon restriction lapse.
  • The RSU restrictions lapse in four annual installments: 5,629 units on February 26, 2027; 5,630 units on February 26, 2028; 5,629 units on February 26, 2029; and 5,630 units on February 26, 2030.
  • Krishna also received a grant of 90,071 Employee Stock Options on February 26, 2026, with an exercise price of $243.22.
  • These stock options vest in four equal annual installments, with the first vesting on February 26, 2027, and all options expiring on February 25, 2036.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a standard and generally positive disclosure of executive compensation, aligning management's interests with long-term shareholder value through equity grants.

Positives

  • The equity grants align the interests of the Chairman, President & CEO, Arvind Krishna, with those of the shareholders, incentivizing long-term performance.
  • The grants represent a standard component of executive compensation, reflecting confidence in the executive's continued leadership and contribution to the company.

Future Outlook

The vesting schedules for the Restricted Stock Units and Employee Stock Options extend through February 2030 and February 2036, respectively, indicating a long-term incentive structure for the CEO.

Industry Context

StockSavvy.ai notes that equity-based compensation, including Restricted Stock Units and stock options, is a prevalent practice among large technology companies like IBM. This approach is widely used to attract, retain, and motivate top executives by linking their personal wealth directly to the company's long-term stock performance, a common strategy seen across the industry with peers such as Microsoft, Oracle, and Accenture.

Comparison to Industry Standards

  • Equity grants are a standard component of executive compensation packages across the technology sector, comparable to practices at companies like Microsoft, Apple, and Google.
  • The structure of multi-year vesting for both RSUs and stock options is consistent with industry best practices designed to promote long-term executive retention and alignment with shareholder interests.
  • The specific number of units and options granted is commensurate with the role of Chairman, President & CEO of a major global technology firm, though the exact value depends on IBM's stock performance relative to its peers.

Stakeholder Impact

  • Shareholders: The equity grants are designed to align the CEO's financial incentives with long-term shareholder value creation, potentially leading to more focused strategic decisions.
  • Employees: Standard executive compensation practices can influence overall company morale and compensation structures, though this filing specifically pertains to the CEO.

Next Steps

  • Vesting of Restricted Stock Units and Employee Stock Options will occur on scheduled dates through 2030 and 2036, respectively.

Key Dates

DateDescription
02/26/2026Date of earliest transaction, representing the grant date for both Restricted Stock Units and Employee Stock Options.
02/27/2026Signature date of the reporting person.
02/26/2027First vesting date for 5,629 Restricted Stock Units and the first of four equal annual installments for Employee Stock Options.
02/26/2028Second vesting date for 5,630 Restricted Stock Units.
02/26/2029Third vesting date for 5,629 Restricted Stock Units.
02/26/2030Fourth and final vesting date for 5,630 Restricted Stock Units.
02/25/2036Expiration date for all granted Employee Stock Options.

Keywords

IBM, Arvind Krishna, Form 4, Equity Grant, Restricted Stock Units, Employee Stock Options, Executive Compensation, Insider Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.